Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1031-1040 Newer>

Smithsonian March 2004 Stephen S. Hall	Kenyon's Ageless Quest A San Francisco scientist's genetic research renews the ancient hope for a way to slow aging. The company, Elixir Pharmaceuticals, in Cambridge, Massachusetts, is developing drugs and other products to treat age-related diseases and slow the process of aging.
Smithsonian March 2004	Signal Discovery? A Los Angeles scientist says living cells may make distinct sounds, which might someday help doctors "hear" diseases
The Motley Fool February 23, 2004 Brian Gorman	Abbott Cleans Up Its Act Abbott closes the books on its problems with the FDA and clears the way to a spinoff. Abbott finally passed FDA muster with its Illinois diagnostics plant. Its multi-year problem highlights the importance of investors monitoring manufacturing while watching a pharmaceutical company's pipeline. And with its FDA compliance issues behind it, Abbott can look forward to spinning off its Hospital Products Division.
InternetNews February 20, 2004 Susan Kuchinskas	Putting an Online Lock On Drugs Sun Microsystems teams with SupplyScape to offer a digital pedigree for pharmaceuticals via RFID.
Entrepreneur March 2004 Jacquelin Lynn	Pick and Save Get with the health-care savings programs!
The Motley Fool February 20, 2004 Alyce Lomax	A Downer for Lilly? The pharmaceutical giant confirms warnings on Zyprexa and the elderly. That warning had to do with a higher incidence of stroke in elderly users suffering from dementia.
InternetNews February 19, 2004 Jim Wagner	Can IBM Ease Health Care Industry's Pain? Big Blue will invest $250M over three years to find ways to use technology to cut rising costs in the sector.
The Motley Fool February 19, 2004 Selena Maranjian	Health-Care Costs' Slow Rise Health-care costs remain a growing problem for many U.S. employers and their employees.
Bio-IT World February 18, 2004	The Quest for Complex Genes Genetic sleuths are homing in on genes for complex diseases with the help of new, and some not so new, tools and strategies.
Bio-IT World February 18, 2004	Strategic Insights High-throughput gene-expression analysis tools are moving rapidly into clinical labs, setting the stage for dramatic improvements in drug development.
<Older 1031-1040 Newer> Return to current articles.